Brevan Howard Capital Management’s Cigna CI Stock Holding History

Brevan Howard Capital Management’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.6M	Buy	+24,745	New	+$6.85M	0.06%	180

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Brevan Howard Capital Management's CI Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Cigna (CI) in Q4 2025, closing a stake of 2,453 shares — an estimated $707K sold.

Brevan Howard Capital Management first reported a position in CI in Q4 2023 and held it in 7 quarters. The position peaked at $22.9M in Q2 2025. 1,654 funds tracked by Wall St. Rank hold CI as of Q4 2025.

Brevan Howard Capital Management reported no remaining Cigna position as of Q4 2025 after selling out during the quarter.
Brevan Howard Capital Management sold 2,453 Cigna shares in Q4 2025, an estimated $707K.
Brevan Howard Capital Management first reported a position in Cigna in Q4 2023 and held it in 7 quarters.
Brevan Howard Capital Management's Cigna position peaked at $22.9M in Q2 2025.
1,654 funds tracked by Wall St. Rank held Cigna as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.